Reuters: Health
A clinical trial of Novartis's Cosentyx drug has failed to prove it is significantly better than a rival treatment for a type of arthritis, the Swiss company said on Friday.
Novartis arthritis drug fails to prove it is significantly better than rival
Novartis arthritis drug fails to prove it is significantly better than rival
Reuters: Health
A clinical trial of Novartis's Cosentyx drug has failed to prove it is significantly better than a rival treatment for a type of arthritis, the Swiss company said on Friday.
Reuters: Health
A clinical trial of Novartis's Cosentyx drug has failed to prove it is significantly better than a rival treatment for a type of arthritis, the Swiss company said on Friday.
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment